Novel biomarkers such as neutrophil gelatinase-associated (NGAL) and kidney injury molecule-1 (KIM-1) are within hours able to detect kidney injury and predict the risk of renal replacement therapy and chronic kidney disease (CKD). This evidence concerns the gene LCN2 and chronic kidney disease.